Abstract:Antigens expressed during the sexual development of malaria parasites are transmission-blocking vaccine (TBV) targets. Pb22, a protein expressed and localized to the plasma membrane of gametes and ookinetes in Plasmodium berghei , is an excellent TBV candidate. Here, we evaluated the TB potential of the Plasmodium vivax ortholog Pv22 using a transgenic P. berghei parasite line and P. vivax clinical isolates. The full-length recombinant Pv22 (rPv22) protein was produced and used to immunize mice and rabbits to obtain antibodies. We generated a transgenic P. berghei line (TrPv22Pb) by inserting the pv22 gene into the pb22 locus and showed that Pv22 expression completely rescued the defects in male gametogenesis of the pb22 deletion parasite. Since Pv22 in the transgenic parasite showed similar expression and localization patterns to Pb22, we used the TrPv22Pb parasite as a surrogate to evaluate the TB potential of Pv22. In mosquito feeding assays, mosquitoes feeding on rPv22-immunized mice infected with TrPv22Pb parasites showed a 49.3–53.3 % reduction in the oocyst density compared to the control group. In vitro assays showed that the rPv22 immune sera significantly inhibited exflagellation and ookinete formation of the TrPv22Pb parasites. In a direct membrane feeding assay using three clinical P. vivax isolates, the rabbit anti-rPv22 antibodies also significantly decreased the oocyst density by 53.7, 30.2, and 26.2 %, respectively. This study demonstrated the feasibility of using transgenic P. berghei parasites expressing P. vivax antigens as a potential tool to evaluate TBV candidates. However, the much weaker TB activity of Pv22 obtained from two complementary assays suggest that Pv22 may not be a promising TBV candidate for P. vivax .

Expression,purification and initial identification of the multi-epitope gene of Plasmodium vivax in Pichia pastoris

Expression of Pf332-DBL Region of Plasmodium Falciparum Membrane Protein in Pichia Pastoris

Expression of Ascaris suum cecropin P1 gene in Pichia pastoris and its antimicrobial activity

Constructing a Pre-Erythrocytic Multi-Epitope Chimeric Antigen of Plasmodium Falciparum and Its Expression in Pichia Pastoris

Expression, Purification and Identification of GRA1 Gene from Toxoplasma Gondii in Pichia Pastoris

Expression of avain infectious bronchitis virus S1 gene in Pichia pastoris

Expression and Characterization of Recombinant Porcine Β-Defensin-2 Gene in Pichia Pastoris

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

[Expression and Characterization of Human Vascular Endothelial Growth Factor in Pichia Pastoris].

Expression in P. pastoris of N-terminal fragment of human bactericidal/permeability-increasing protein

Expression and the Immune Response of the EGF2 Domain in the Merozoite Surface Protein 1 of Plasmodium Faciparum

Truncated expression and identification of the peste des petits ruminants virus M gene

Expression and Characterization of HIV-1 Envelope Glycoprotein in Pichia Pastoris

Prokaryotic Expression and Preparation of Polyclonal Antibody of Heparin Binding Protein PF3D7_1104400 of Plasmodium falciparum

[Synthesis and Expression of 42 Kd C-terminal Region of the Major Merozoite Surface Protein (MSP1 - 42) of P. Falciparum 3D7 Strain in Pichia Pastoris].

Expression of vascular basement membrane-derived multifunctional peptide in Pichia pastoris and identification of its bioactivity

Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei

Expression of Avain Infectious Bronchitis Virus M Gene in Pichia Pastoris and Bio-Activity Assay

Expression of Japanese Encephalitis Virus E Protein in Methylotrophic Yeast Pichia Pastoris

Construction of eukaryotic expression vector of OmpK of Vibrio harveyi and identification of protein expression in Pichia pastoris

Expression of HIV-2 Gp 105 Gene and Characterization of Gp105 in Methyltrophic Pichia Pastoris.